Related Experiment Video

Updated: Jun 25, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

[Tenofovir as a strategy to avoid or limit adverse effects]

Joaquín Portilla1

  • 1Unidad de Enfermedades Infecciosas, Hospital General Universitario de Alicante, Alicante, España. portilla_joa@gva.es

Enfermedades Infecciosas Y Microbiologia Clinica
|February 7, 2009
PubMed

Insights

Substituting thymidine analogues like stavudine and zidovudine with tenofovir DF improves lipoatrophy and metabolic profiles in patients. This switch maintains antiretroviral therapy efficacy while mitigating adverse effects.

Area of Science:

  • Pharmacology
  • Virology
  • Metabolic Medicine

Context:

  • Thymidine analogues (stavudine, zidovudine) used in antiretroviral therapy can cause mitochondrial DNA depletion, leading to adverse effects like lipodystrophy.
  • Lipoatrophy, a significant side effect, lacks specific treatments and is linked to thymidine analogue exposure.

Purpose:

  • To evaluate the effects of substituting thymidine analogues with tenofovir DF on lipoatrophy and other antiretroviral therapy-related side effects.
  • To assess the impact of this substitution on body fat distribution, metabolic profiles, and hemoglobin levels.

Summary:

  • Prospective observational studies and randomized clinical trials involving over 2000 patients show that switching from thymidine analogues to tenofovir DF increases total body fat, particularly in the face and extremities.
  • This substitution improves lipid and metabolic profiles and elevates hemoglobin levels upon discontinuation of zidovudine.
  • Antiviral and immunological efficacy of the antiretroviral therapy is maintained or enhanced.

Impact:

  • The substitution strategy is strongly recommended for antiretroviral therapy due to robust scientific data demonstrating improved lipoatrophy and metabolic outcomes.
  • This approach offers a viable solution for managing adverse effects associated with thymidine analogue use in HIV treatment.

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors05:46

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Related Concept Videos

Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Retroviruses02:33

Retroviruses

Retroviruses and retrotransposons both insert copies of their genetic elements into the genome of the host cell. Thus, the viral genes are passed on when the host genome is replicated or translated. A typical retroviral DNA sequence contains 3-4 genes that encode the different proteins required for its structural assembly and function as a molecular parasite. This DNA is transcribed into a single mRNA, which is very similar in structure to conventional mRNAs, i.e., it is capped at the 5’...
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...